XML 49 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash flows from operating activities:    
Net income $ 24,537 $ 20,622
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and other 101,168 86,654
Share-based compensation expense 3,279 5,129
Bad debt expense 485 107
Gain on sales of real estate (11,766) 0
Loss on extinguishment of debt, net 4,663 0
Change in fair value of derivative financial instruments 857 (8,573)
Changes in operating assets and liabilities:    
Receivables and other assets, net (4,443) (13,569)
Accounts payable and accrued liabilities 13,212 21,928
Security deposits, prepaid rent and other liabilities (2,442) 6,377
Net cash provided by operating activities 129,550 118,675
Cash flows from investing activities:    
Acquisition of real estate operating properties (229,644) (223,839)
Proceeds from sales of real estate 40,148 0
Capital expenditures (24,167) (16,486)
Collection of real estate notes receivable 20,000 0
Issuance of real estate notes receivable 0 (8,520)
Restricted cash, escrow deposits and other assets (29,318) (2,446)
Net cash used in investing activities (222,981) (251,291)
Cash flows from financing activities:    
Proceeds from unsecured senior notes 297,615 297,558
Borrowings on unsecured revolving credit facility 213,000 103,000
Payments on unsecured revolving credit facility (233,000) (175,000)
Payments on secured real estate term loan and mortgage loans (90,389) (155,302)
Deferred financing costs (6,093) (3,471)
Derivative financial instrument termination payments 0 (1,195)
Security deposits (1,245) 967
Proceeds from issuance of common stock, net 18,016 229,498
Repurchase and cancellation of common stock (572) (287)
Dividends (102,506) (95,597)
Payment on earnout liability 0 (92)
Distributions to noncontrolling interest of limited partners (1,061) (1,238)
Net cash provided by financing activities 93,765 198,841
Net change in cash and cash equivalents 334 66,225
Cash and cash equivalents - beginning of period 18,081 15,956
Cash and cash equivalents - end of period 18,415 82,181
Healthcare Trust of America Holdings, LP (HTALP)
   
Cash flows from operating activities:    
Net income 24,537 20,622
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and other 101,168 86,654
Share-based compensation expense 3,279 5,129
Bad debt expense 485 107
Gain on sales of real estate (11,766) 0
Loss on extinguishment of debt, net 4,663 0
Change in fair value of derivative financial instruments 857 (8,573)
Changes in operating assets and liabilities:    
Receivables and other assets, net (4,443) (13,569)
Accounts payable and accrued liabilities 13,212 21,928
Security deposits, prepaid rent and other liabilities (2,442) 6,377
Net cash provided by operating activities 129,550 118,675
Cash flows from investing activities:    
Acquisition of real estate operating properties (229,644) (223,839)
Proceeds from sales of real estate 40,148 0
Capital expenditures (24,167) (16,486)
Collection of real estate notes receivable 20,000 0
Issuance of real estate notes receivable 0 (8,520)
Restricted cash, escrow deposits and other assets (29,318) (2,446)
Net cash used in investing activities (222,981) (251,291)
Cash flows from financing activities:    
Proceeds from unsecured senior notes 297,615 297,558
Borrowings on unsecured revolving credit facility 213,000 103,000
Payments on unsecured revolving credit facility (233,000) (175,000)
Payments on secured real estate term loan and mortgage loans (90,389) (155,302)
Deferred financing costs (6,093) (3,471)
Derivative financial instrument termination payments 0 (1,195)
Security deposits (1,245) 967
Proceeds from issuance of general partner units, net 18,016 229,498
Repurchase and cancellation of general partner units (572) (287)
Distributions to general partner (102,506) (95,597)
Payment on earnout liability 0 (92)
Distributions to limited partners and redeemable noncontrolling interests (1,061) (1,238)
Net cash provided by financing activities 93,765 198,841
Net change in cash and cash equivalents 334 66,225
Cash and cash equivalents - beginning of period 18,081 15,956
Cash and cash equivalents - end of period $ 18,415 $ 82,181